InvestorsHub Logo
Followers 210
Posts 23995
Boards Moderated 5
Alias Born 10/25/2003

Re: None

Wednesday, 08/08/2018 6:18:12 PM

Wednesday, August 08, 2018 6:18:12 PM

Post# of 58002
Another question for the board, why is CSTI - CANACCORD GENUITY LLC the top market maker on ASFX = http://otce.finra.org/MonthlyShareVolume doing so much volume in this security?

Canaccord Genuity LLC Offering History
https://www.nasdaq.com/markets/ipos/offering-history.aspx?expert=canaccord+genuity+llc

These guys are most definitely not arcane minutia.
Their commercial clientele are global.
https://www.canaccordgenuity.com/capital-markets/
https://www.canaccordgenuity.com/

>>>>>>>>>>>>>> $$$ Canaccord Genuity Growth Conference $$$ <<<<<<<<<<<<<<<<<<<

August 9, 2018
Presentation – 2:00 p.m. Local Time
Boston, Massachusetts

These guys are open for business. If you're in business you have to have something to sell.

http://www.tpicomposites.com/English/investors/Events-and-Presentations/events/event-details/2017/Canaccord-Conference/default.aspx

If this isn't big daddy deep pocket I don't know what is.
Take a gander at past participants;
http://www.tpicomposites.com/English/investors/Events-and-Presentations/events/default.aspx

TPI Composites, Inc. to Participate at Upcoming Investor Conferences
http://www.tpicomposites.com/English/newsroom/press-releases/press-release-details/2018/TPI-Composites-Inc-to-Participate-at-Upcoming-Investor-Conferences-edfe0113e/default.aspx

Imprimis Pharmaceuticals to Present at the Canaccord Genuity 38th Annual Growth Conference on August 9, 2018
https://www.bizjournals.com/sacramento/prnewswire/press_releases/California/2018/07/18/LA56191

Exact Sciences to participate in Canaccord Genuity Growth Conference
https://finance.yahoo.com/news/exact-sciences-participate-canaccord-genuity-100000564.html

And on and on.....

Wayfair to Participate in the Canaccord Genuity 38th Annual Growth Conference
https://www.businesswire.com/news/home/20180808005163/en/Wayfair-Participate-Canaccord-Genuity-38th-Annual-Growth

CERES Coin to Present at 38th Annual Canaccord Genuity Growth Conference in Boston

CERES Coin will present at the Blockchain and Digital Asset Symposium on August 7th, as a prelude to the Growth Conference on August 8th and 9th.

CHICAGO (PRWEB) August 01, 2018

On August 7th, Canaccord Genuity, the global capital markets division of Canaccord Genuity Group Inc, will host its 38th Annual Growth Conference in Boston. This year, CERES Coin, a blockchain transaction network in the cannabis industry, will present to investors on the Blockchain and Digital Asset Symposium stage.

When you think of the cannabis industry, you may not immediately think of the blockchain or a security token offering, but CERES Coin is betting big that this will change in the near future. The startup is seeking to launch the world’s first SEC-compliant Security Token Offering (STO) in the cannabis industry this year, and they’re already well on their way to succeeding. They’re poised to disrupt the industry in a way we haven’t seen since state-led legalization.

Founders Charlie Uchill and Greg Anderson launched CERES after seeing significant issues in the cannabis market – specifically in funding, banking, and transactions in the industry. Since the sector is “unbanked” aka, banks refuse to finance cannabis ventures, it’s up to cannabis startups, of which there are many, to turn to the private sector for funds.

Ambitious ICO founders have jumped at the opportunity to bring in funding, but Uchill and Anderson know what many investors have discovered over the last few years - ICOs are unstable at best and fraudulent at worst. Uchill and Anderson understand that the problems facing the cannabis industry (ease of brokering transactions, regulation and oversight, and lack of funding) can’t be solved with cryptocurrency alone. Only a security, backed with the full support of the SEC, will bring the cannabis industry from a niche market to the masses. A regulated STO can benefit both companies and investors and allow the cannabis industry to flourish.

No strangers to an uphill battle (founders Charlie Uchill and Greg Anderson are USMA grads, and Uchill is a former U.S. Army Ranger), CERES is willing to push hard to make their dream a reality. And they have proven time and time again that their instincts are right on the money. They are excited to speak at the conference and look forward to meeting other change-makers in the space.

About CERES Coin: Founded in 2017, CERES Coin is a blockchain transaction network for the cannabis industry. The company hopes to launch the first ever SEC-compliant STO in 2018.

For more information, visit CERES’ website at http://www.cerescoin.io.

No money or other consideration is being solicited with respect to the offering described herein, and if sent in response, will not be accepted. No offer to buy the securities described herein can be accepted and no part of the purchase price for such securities can be received unless and until an offering statement with respect to the offer and sale of such securities has been filed with, and fully qualified by, the sec. Any such offer May be withdrawn or revoked, without obligation or commitment of any kind, at any time before notice of acceptance.

Contact:
CERES Coin
Charlie Uchill, COO
(773) 354-2301
charlie@cerescoin.io
http://www.cerescoin.io

https://www.prweb.com/releases/ceres_coin_to_present_at_38th_annual_canaccord_genuity_growth_conference_in_boston/prweb15664987.htm
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Ok, what's your point Mariner* your drifting here.
My point is ASFX is fixing to be a marketable security and there are some heavy hitters that are picking up stock on that eventuality.
Just saying, if there's smoke, there's fire and it's getting real smoky around here of late.
M-